Recalling firm
DermaRite Industries, LLC
Product type
Drug
Status
Ongoing
Report date
2025-11-26
Distribution
Nationwide in the USA
Firm state
NJ
Product quantity
8,378 containers
Initiated by
Voluntary: Firm initiated
SPEQ quality domain
Environmental MonitoringReason for recall
CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.
Product description
Lantiseptic, Dry Skin Therapy, Lanolin USP 30%, packaged in a) 5 g (0.17 oz) (NDC 61924-504-05), b) 4 oz (NDC 61924-504-04), and c)14 oz (NDC 61924-710-14) tubes, DermaRite Industries LLC, 7777 West Side Avenue, North Bergen, NJ 07047.
Code / lot info
All lots on or before expiry date 08/2027
Other recalls SPEQ maps to Environmental Monitoring
See all Environmental Monitoring recalls →Data: U.S. FDA openFDA enforcement API. Recall details are as reported by the FDA. The quality-domain mapping and severity are a SPEQ editorial interpretation of the recall reason, not an official FDA classification.